Evaluation of sustained release matrix tablets:
DESIGN AND IN VITRO EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF LORNOXICAM
12
FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF TRAMADOL HYDROCHLORIDE
11
FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF PIOGLITAZONE
22
FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF RANOLAZINE
6
FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF NATEGLINIDE
7
Formulation and Evaluation of Sustained Release Matrix Tablets of Zidovudine
9
Formulation and Evaluation of Sustained Release Matrix Tablets of Losartan
10
Formulation and evaluation of sustained release matrix tablets of nifedipine
10
FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF CAPTOPRIL
6
Formulation and Evaluation of Sustained Release Matrix Tablets of Venlafaxine Hydrochloride
168
Formulation and In-Vitro Evaluation of Sustained Release Matrix Tablets of Gliclazide
144
Formulation and Invitro Evaluation of Sustained Release Matrix Tablets of Ibuprofen.
165
Formulation and Evaluation of Sustained-Release Matrix Tablets of Timolol Maleate.
141
FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF LOSARTAN POTASSIUM
7
FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF TAPENTADOL HCL
14
FORMULATION AND IN-VITRO EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF LEVOFLOXACIN
9
FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF MONTELUKAST SODIUM
9
FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF ATENOLOL HYDROCHLORIDE
10
Formulation and Evaluation of Sustained Release Matrix Tablets of Quetiapine Fumarate
5
FORMULATION AND EVALUATION OF SUSTAINED-RELEASE MATRIX TABLETS OF TIMOLOL MALEATE
18